Ufmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) form

Experimental and Molecular Pathology

Volumn 97, Issue 1, 2014, Pages 81-88

  Liu, H ^a   Li, J ^a   Tillman, B ^a   French, B A ^a   French, S W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

FAT10; Mallory Denk bodies (MDBs); Transcript regulation; Ubiquitin like (Ubl) modifiers; Ufm1

Indexed keywords

DIETHYL 1,4 DEHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINE DICARBOXYLATE; MESSENGER RNA; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONJUGATION; CONTROLLED STUDY; DOWN REGULATION; FAT10 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LMP2 GENE; LMP7 GENE; MALLORY BODY; MALLORY DENK BODY; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; UBA5 GENE; UBA6 GENE; UFC1 GENE; UFL1 GENE; UFM1 GENE; UFSP1 GENE; UFSP2 GENE; UPREGULATION; USE1 GENE;

FAT10; MALLORY-DENK BODIES (MDBS); TRANSCRIPT REGULATION; UBIQUITIN-LIKE (UBL) MODIFIERS; UFM1;

ANIMALS; CASE-CONTROL STUDIES; DOWN-REGULATION; FATTY LIVER; GENE EXPRESSION REGULATION; HEPATITIS, ALCOHOLIC; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MALLORY BODIES; MICE; MICE, INBRED C3H; PROTEINS; PYRIDINES; UBIQUITIN-ACTIVATING ENZYMES; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINS;

EID: 84901987040     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.05.010     Document Type: Article

References (31)

1. Aichem A., Kalveram B., Spinnenhirn V., Kluge K., Catone N., Johansen T., Groettrup M. The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation. J. Cell Sci. 2012, 125:4576-4585.
2. Bardag-Gorce F., Vu J., Nan L., Riley N., Li J., French S.W. Proteasome inhibition induces cytokeratin accumulation in vivo. Exp. Mol. Pathol. 2004, 76:83-89.
3. Bardag-Gorce F., Oliva J., Li J., French B.A., French S.W. SAMe prevents the induction of the immunoproteasome and preserves the 26S proteasome in the DDC-induced MDB mouse model. Exp. Mol. Pathol. 2010, 88:353-362.
4. Cajee U.F., Hull R., Ntwasa M. Modification by ubiquitin-like proteins: significance in apoptosis and autophagy pathways. Int. J. Mol. Sci. 2012, 13:11804-11831.
5. Chen J., Yang L., Chen H., Yuan T., Liu M., Chen P. Recombinant adenovirus encoding FAT10 small interfering RNA inhibits HCC growth in vitro and in vivo. Exp. Mol. Pathol. 2014, 96:207-211.
6. Chiu Y.H., Sun Q., Chen Z.J. E1-L2 activates both ubiquitin and FAT10. Mol. Cell 2007, 27:1014-1023.
7. French S.W., Bardag-Gorce F., Li J., French B.A., Oliva J. Mallory-Denk body pathogenesis revisited. World J. Hepatol. 2010, 2:295-301.
8. Fu H., Lin Y.L., Fatimababy A.S. Proteasomal recognition of ubiquitylated substrates. Trends Plant Sci. 2010, 15:375-386.
9. Gavin J.M., Chen J.J., Liao H., Rollins N., Yang X., Xu Q., Ma J., Loke H.K., Lingaraj T., Brownell J.E., Mallender W.D., Gould A.E., Amidon B.S., Dick L.R. Mechanistic studies on activation of ubiquitin and di-ubiquitin-like protein, FAT10, by ubiquitin-like modifier activating enzyme 6, Uba6. J. Biol. Chem. 2012, 287:15512-15522.
10. Hershko A. The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle. Cell Death Differ. 2005, 12:1191-1197.
11. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 1998, 67:425-479.
12. Kang S.H., Kim G.R., Seong M., Baek S.H., Seol J.H., Bang O.S., Ovaa H., Tatsumi K., Komatsu M., Tanaka K., Chung C.H. Two novel ubiquitin-fold modifier 1 (Ufm1)-specific proteases, UfSP1 and UfSP2. J. Biol. Chem. 2007, 282:5256-5262.
13. Kerscher O., Felberbaum R., Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 2006, 22:159-180.
14. Lee C.G., Ren J., Cheong I.S., Ban K.H., Ooi L.L., Yong Tan S., Kan A., Nuchprayoon I., Jin R., Lee K.H., Choti M., Lee L.A. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 2003, 22:2592-2603.
15. Li J., Bardag-Gorce F., Dedes J., French B.A., Amidi F., Oliva J., French S.W. S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting the epigenetic memory. Hepatology 2008, 47:613-624.
16. Lim C.B., Zhang D., Lee C.G. FAT10, a gene up-regulated in various cancers, is cell-cycle regulated. Cell Div. 2006, 1:20.
17. Lukasiak S., Schiller C., Oehlschlaeger P., Schmidtke G., Krause P., Legler D.F., Autschbach F., Schirmacher P., Breuhahn K., Groettrup M. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene 2008, 27:6068-6074.
18. Merbl Y., Refour P., Patel H., Springer M., Kirschner M.W. Profiling of ubiquitin-like modifications reveals features of mitotic control. Cell 2013, 152:1160-1172.
19. Mukhopadhyay D., Riezman H. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 2007, 315:201-205.
20. Nakanuma Y., Ohta G. Is mallory body formation a preneoplastic change? A study of 181 cases of liver bearing hepatocellular carcinoma and 82 cases of cirrhosis. Cancer 1985, 55:2400-2404.
21. Oliva J., Bardag-Gorce F., French B.A., Li J., McPhaul L., Amidi F., Dedes J., Habibi A., Nguyen S., French S.W. Fat10 is an epigenetic marker for liver preneoplasia in a drug-primed mouse model of tumorigenesis. Exp. Mol. Pathol. 2008, 84:102-112.
22. Oliva J., Bardag-Gorce F., Li J., French B.A., Nguyen S.K., Lu S.C., French S.W. Betaine prevents Mallory-Denk body formation in drug-primed mice by epigenetic mechanisms. Exp. Mol. Pathol. 2009, 86:77-86.
23. Oliva J., Bardag-Gorce F., Lin A., French B.A., French S.W. The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomes. Exp. Mol. Pathol. 2010, 89:1-8.
24. Qing X., French B.A., Oliva J., French S.W. Increased expression of FAT10 in colon benign, premalignant and malignant epithelial neoplasms. Exp. Mol. Pathol. 2011, 90:51-54.
25. Raasi S., Schmidtke G., de Giuli R., Groettrup M. A ubiquitin-like protein which is synergistically inducible by interferon-gamma and tumor necrosis factor-alpha. Eur. J. Immunol. 1999, 29:4030-4036.
26. Raasi S., Schmidtke G., Groettrup M. The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J. Biol. Chem. 2001, 276:35334-35343.
27. Rape M. Tumor suppression by mitotic quality control (472.1). FASEB J. 2014, 28(1). (Supplement 472.1).
28. Schmidtke G., Aichem A., Groettrup M. FAT10ylation as a signal for proteasomal degradation. Biochim. Biophys. Acta 2013, 1843:97-102.
29. Tatsumi K., Sou Y.S., Tada N., Nakamura E., Iemura S., Natsume T., Kang S.H., Chung C.H., Kasahara M., Kominami E., Yamamoto M., Tanaka K., Komatsu M. A novel type of E3 ligase for the Ufm1 conjugation system. J. Biol. Chem. 2009, 285:5417-5427.
30. Tatsumi K., Yamamoto-Mukai H., Shimizu R., Waguri S., Sou Y.S., Sakamoto A., Taya C., Shitara H., Hara T., Chung C.H., Tanaka K., Yamamoto M., Komatsu M. The Ufm1-activating enzyme Uba5 is indispensable for erythroid differentiation in mice. Nat. Commun. 2011, 2:181.
31. Zatloukal K., French S.W., Stumptner C., Strnad P., Harada M., Toivola D.M., Cadrin M., Omary M.B. From Mallory to Mallory-Denk bodies: what, how and why?. Exp. Cell Res. 2007, 313:2033-2049.